SOX2 and neoplasm: In a heterotopic xenograft mouse model, DAP was intraperitoneally administered to immunocompromised mice, which significantly reduced tumor volume and weight and SOX2-positive cells in tumors (Fig. 7A–D), indicating the reduction of OSC stemness and tumorigenicity.